News Wearable biosensor can monitor oestrogen in sweat Researchers in the US have developed a prototype of a wearable device that can monitor oestrogen in sweat and could play a role in women’s health and fertility.
News Study adds to HRT and Alzheimer's debate Hormone replacement therapy (HRT) could cut the risk of Alzheimer's in some women at elevated risk of the disease, according to researchers in the UK.
News HRT tablets linked to higher blood clot risk: study Certain types of hormone replacement therapy (HRT) could lead to increased risk of venous thromboembolism (VTE), a new study has suggested.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.